WeVote
Log In

Bill

Bill

SB 1414

Insurance, Health, Accident - As enacted, revises present law relative to 340B entities. - Amends TCA Title 47, Chapter 18 and Title 56.

114th Regular Session (2025-2026) Introduced by Richard Briggs

Tennessee revises 340B drug pricing program regulations to modify how eligible healthcare entities and nonprofits can access discounted pharmaceutical purchases.

Pub. Ch. 404
#accident #health #insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 1414

Legislative bill overview

SB 1414 modifies Tennessee's regulations governing 340B entities—organizations that participate in the federal 340B Drug Pricing Program, which allows certain healthcare providers, charities, and patient assistance programs to purchase medications at discounted prices. The bill amends provisions in Tennessee Code Annotated Title 47 (Insurance) and Title 56 (Health) to revise how these entities operate within the state.

Why is this important

The 340B program significantly impacts drug pricing accessibility for uninsured and low-income patients, as well as operating costs for hospitals, clinics, and nonprofits. Changes to state-level 340B regulations can affect drug affordability, pharmaceutical company compliance practices, and the financial sustainability of healthcare providers that serve vulnerable populations.

Potential points of contention

  • Program scope and oversight – Unclear whether revisions expand or restrict which entities qualify as 340B participants, or how state oversight is enforced
  • Pharmaceutical industry interests – Drug manufacturers may oppose stricter regulations on 340B participation, while advocates may want stronger protections against program abuse
  • Healthcare provider impact – Hospitals and nonprofits depend on 340B discounts for operations; changes could affect their financial viability or service capacity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.